Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 32 of 32 publications.

Merola JF, Werth V, Choi JC, Becker B, Edwards T, Hobar C, Pomponi S, Strand V. Qualitative patient interview study in patients with systemic lupus erythematosus to assess patient perception of fatigue and skin-related symptoms. Poster presented at the American College of Rheumatology (ACR) Convergence 2024; November 17, 2024. Washington, DC. [abstract] Arthritis Rheumatol. 2024; 76(suppl 9).

Arends S, Choi JC, Becker B, Edwards T, Sreih A, Christodoulou A, Strand V. Qualitative study on patient-reported outcome measures in patients with Sjogren's disease. Poster presented at the American College of Rheumatology (ACR) Convergence 2024; November 17, 2024. Washington, DC. [abstract] Arthritis Rheumatol. 2024; 76(suppl 9).

Starzyk K, Hoffman V, Su Z, Meng R, Bhartia M, Curhan G, Yoshida K, Paulus JK. More than half of patients with a rheumatic disease or immunologic condition undergoing methotrexate treatment reside in states in which the overturning of Roe v. Wade can jeopardize access to medications with abortifacient potential. Arthritis Rheumatol. 2023 Feb;75(2):328-9. doi: 10.1002/art.42398

Ardeshirrouhanifard S, An H, Goyal RK, Raji M, Segal J, Alexander GC, Mehta HB. Initiation and switching of direct oral anticoagulants among Medicare beneficiaries with cancer and atrial fibrillation. Poster presented at the 2021 American Heart Association, Epidemiology Scientific Session; May 2021. [abstract] Circulation. 2021 May 25; 143(Suppl 1):AP148.

Bell CF, Meyers J, Ajmera M. Incremental healthcare costs of Eosinophilic Granulomatosis with Polyangiitis (EGPA) compared to asthma: retrospective analysis of commercial claims data in the United States (US). Poster presented at the 2021 Virtual American College of Rheumatology (ACR) Convergence; November 6, 2021. [abstract] Arthritis Rheumatol. 2021; 73(Suppl 10).

Doyle S, Njue A, Lyall M, Rushton R, Heyes A, Kelly M. Systematic review of the clinical effectiveness of treatments in eosinophilic granulomatosis with polyangiitis. Poster presented at the 2018 ACR/ARHP Annual Meeting; October 22, 2018. Chicago, IL. [abstract] Arthritis Rheumatol. 2018 Sep; 70(S9):1944. doi: 10.1002/art.40700

Doyle S, Moss E, Hartley L, Knight C, Bell J, Ahdesmaki O, Kelly M. An economic systematic literature review of eosinophilic granulomatosis with polyangiitis. Poster presented at the 2018 ACR/ARHP Annual Meeting; October 22, 2018. Chicago, IL. [abstract] Arthritis Rheumatol. 2018 Sep; 70(S9):1953. doi: 10.1002/art.40700

Abdul-Jawad Altisent O, Puri R, Regueiro A, Chamandi C, Rodriguez-Gabella T, Del Trigo M, Campelo-Parada F, Couture T, Marsal JR, Cote M, Paradis JM, DeLarochellière R, Doyle D, Mohammadi S, Dumont E, Rodes-Cabau J. Predictors and association with clinical outcomes of the changes in exercise capacity after transcatheter aortic valve replacement. Circulation. 2017 Aug 15;136(7):632-43. doi: 10.1161/CIRCULATIONAHA.116.026349

Davidson J, Fu Q, Ji B, Rao S, Roth D, Magder LS, Petri M. The long-term clinical outcomes of lupus nephritis. Poster presented at the 2016 ACR/ARHP Annual Meeting; November 11, 2016. Washington, DC. [abstract] Arthritis Rheumatol. 2016 Oct; 68(suppl 10). doi: 10.1002/art.39977

Hoffman E, Mladsi DM, Cryer B, Hopkins W, Brater DC, Parikh R, Goyal R, Castellsague J, Stafkey-Mailey D, Young C. Dose-related risks of cardiovascular, gastrointestinal, and renal adverse events associated with meloxicam among patients with osteoarthritis: an observational study using US claims data. Poster presented at the 2016 ACR/ARHP Annual Meeting; November 15, 2016. Washington, DC. [abstract] Arthritis Rheumatol. 2016 Sep 28; 68(Suppl 10).

Gossec L, Kvien TK, Conaghan PG, Ostergaard M, Canete JD, Gaillez C, Mpofu S, Sherif B, Jugl S. Relationship between improvements in fatigue and signs & symptoms of active psoriatic: arthritis a sub-analysis of a phase 3 study with secukinumab. Poster presented at the 2015 ACR/ARHP Annual Meeting; November 10, 2015. San Francisco, CA. [abstract] Arthritis Rheumatol. 2015 Sep 29; 67(Suppl 10).

Druce KL, Jones GT, Macfarlane GJ, Basu N. Determining pathways to improvements in fatigue in rheumatoid arthritis: results from the British society for rheumatology biologics register for rheumatoid arthritis. Arthritis Rheumatol. 2015 Sep;67(9):2303-10. doi: 10.1002/art.39238

Accortt N, Anthony MS, Schenfeld J, Wheeling T, Hassebroek A, O'Malley CD, Sprafka M. Incidence and prevalence of myasthenia gravis in rheumatoid arthritis patients with and without treatment compared with the general population. Poster presented at the 2014 ACR/ARHP Annual Meeting; November 2014. Boston, MA. [abstract] Arthritis Rheumatol. 2014 Oct; 66(Suppl 1):S895.

Davis AE, Mehrotra S, Friedewald J, Ladner D. Characteristics of a simulation model of the national kidney transplantation system. Poster presented at the 2013 Winter Simulation Conference: Simulation: Making Decisions in a Complex World; December 2013. [abstract] Ieee/Acm Trans Comput Biol Bioinform. 2013 Dec; p.2320-9.

Ferreira-Gonzalez I, Marsal JR, Ribera A, Permanyer-Miralda G, Garcia-Del Blanco B, Marti G, Cascant P, Martin-Yuste V, Brugaletta S, Sabate M, Alfonso F, Capote ML, De La Torre JM, Ruiz-Lera M, Sanmiguel D, Cardenas M, Pujol B, Baz JA, Iniguez A, Trillo R, Gonzalez-Bejar O, Casanova J, Sanchez-Gila J, Garcia-Dorado D. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation. 2010 Sep 7;122(10):1017-25. doi: 10.1161/CIRCULATIONAHA.110.938290

Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation. 2002 Jan 1;106(23):2919-24.

Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Williams JK. The atheroprotective effect to dietary soy isoflavones in apolipoprotein E -/- mice requires the presence of estrogen receptor-a. Circulation. 2002;p.106.

Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Evans GE, Liao D. Prospective association between hormone replacement therapy and the QT index. Circulation. 2001;104:II-792.

Varas-Lorenzo C, Garcia-Rodriguez LA, Perez-Gutthann S, Duque-Oliart A. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation. 2000 Jun 6;101(22):2572-8.

Anthony MS, Clarkson TB, Evans GW. Estrogen-only versus estrogen + progestin replacement therapy: effects on coronary artery atherosclerosis extent and carotid artery intima-media thickness. Presented at the 40th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, American Heart Association; March 1, 2000. San Diego, CA. [abstract] Circulation. 2000; 101(6):714.

Helliwell PS, Doward L, Whalley D, Tennant A, McKenna S, Reynolds S, Kay L, Spoorenberg A, van der Heijde Leeds D. Psychometric and scaling properties of a new quality of life instrument specific to ankylosing spondylitis (AS). Poster presented at the 1999 ACR/ARHP Annual Scientific Meeting; November 14, 1999. Boston, MA. [abstract] Arthritis Rheumatol. 1999 Sep; 42(S9):s72.

Williams K, Anthony MS, Andersen HL. A comparison of plant and mammalian estrogens on dilator and constrictor responses of atherosclerotic coronary arteries in postmenopausal monkeys. Circulation. 1998 Oct;98(Suppl I):I-463.

Clarkson TB, Anthony MS. Effect of hormone replacement therapy on internal carotid artery atherosclerosis on postmenopausal monkeys. Circulation. 1998;97:830.

Anthony MS, Clarkson TB. Comparison of soy phytoestrogens and conjugated equine estrogens on atherosclerosis progression on postmenopausal monkeys. Presented at the 38th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; March 1998. Sante Fe, NM. [abstract] Circulation. 1998; 97:829.

Williams JK, Sukhova Gk, Anthony MS, Libby P. The cholesterol-lowering independent effects of pravastatin on the artery wall of monkeys. Circulation. 1997;96(Suppl I):I-607.

Anthony MS, Clarkson TB, Bullock BC. Soy protein versus soy phytoestrogens (isoflavones) in the prevention of coronary artery atherosclerosis of cynomolgus monkeys. Presented at the 69th Scientific Sessions of the American Heart Association; November 1996. New Orleans, LA. [abstract] Circulation. 1996; 94(Suppl I):I-265.

Moran CM, Fleming AD, Sutherland GR, Anderson T, McDicken WN. An evaluation of the properties of myocardial color Doppler energy mapping using test phantoms. Circulation. 1995 Oct 15;92(8):71.

Kaplan JR, Clarkson TB, Adams MR, Anthony MS, Manuck SB, Morgan TM. Oral contraceptives inhibit atherogenesis in female monkeys at high risk due to social subordination. Circulation. 1995;92(Suppl I):I-627.

Honoré EK, Williams JK, Anthony MS. Enhancement of coronary vasodilation by soy phytoestrogens. Circulation. 1995;92(Suppl I):I-349.

Anthony MS, Burke GL, Hughes CLJr, Clarkson TB. Does soy supplementation improve Coronary Heart Disease (CHD) risk? Presented at the 35th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, American Heart Association; March 1995. San Antonio, TX. [abstract] Circulation. 1995; 91:925.

Anthony MS, Clarkson TB, Hughes CL. Plant and mammalian estrogen effects on plasma lipids of female monkeys. Presented at the 67th Annual Scientific Sessions, American Heart Association; November 1994. Dallas, TX. [abstract] Circulation. 1994; 90:I-235.

Anthony MS, Crouse JR. Heterogeneity in plasma lipoprotein response to dietary fish oil. Presented at the 61st Scientific Sessions of the American Heart Association; November 1988. Washington, DC. [abstract] Circulation. 1988; 78(Suppl II):571. Previously presented at the 8th International Symposium on Atherosclerosis.